Ivar Skaland

1.9k citations

66 papers · 1.5k indexed · h-index 23

Co-authors: Einar Gudlaugsson Jan P. A. Baak Emiel A. M. Janssen Håvard Søiland Jan Kłos Kjell H. Kjellevold Anaís Malpica Irene Tveiterås Øvestad
Topics: Breast Cancer Treatment Studies (22 papers)HER2/EGFR in Cancer Research (13 papers)Cervical Cancer and HPV Research (13 papers)
Cited by: Cancer Research Obstetrics and Gynecology Oncology
Journals: SHILAP Revista de lepidopterologíaPLoS ONE International Journal of Molecular Sciences
Partner nations: Norway Netherlands United States

In The Last Decade

Ivar Skaland

65 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ivar Skaland

Since Specialization

Citations

This map shows the geographic impact of Ivar Skaland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivar Skaland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivar Skaland more than expected).

Fields of papers citing papers by Ivar Skaland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivar Skaland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivar Skaland. The network helps show where Ivar Skaland may publish in the future.

Co-authorship network of co-authors of Ivar Skaland

This figure shows the co-authorship network connecting the top 25 collaborators of Ivar Skaland. A scholar is included among the top collaborators of Ivar Skaland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivar Skaland. Ivar Skaland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Automated Prognostic Assessment of Endometrial Hyperplasia for Progression Risk Evaluation Using Artificial Intelligence 2023 ·Modern Pathology ·(unknown),Einar Gudlaugsson,(unknown),Ivar Skaland,Jan P. A. Baak,Emiel A. M. Janssen	4
2	A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment 2021 ·Cancer Immunology Immunotherapy ·(unknown),Martin Watson,Ivar Skaland,Hanne R. Hagland,(unknown),Einar Gudlaugsson,Kjetil Søreide	11
3	<p>Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients</p> 2020 ·Clinical Epidemiology ·(unknown),Kristín Jónsdóttir,(unknown),Ivar Skaland,Cathrine F. Hjorth,Einar Gudlaugsson,Stephen Hamilton‐Dutoit,Timothy L. Lash,Deirdre Cronin‐Fenton,Emiel A. M. Janssen	4
4	Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer 2020 ·PLoS ONE ·(unknown),(unknown),(unknown),Einar Gudlaugsson,(unknown),Ivar Skaland,Jan P. A. Baak,Emiel A. M. Janssen	5
5	Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients 2019 ·PLoS ONE ·(unknown),Marie Austdal,(unknown),(unknown),Einar Gudlaugsson,Jan P. A. Baak,Ivar Skaland,Emiel A. M. Janssen,Kristín Jónsdóttir	8
6	Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial 2019 ·BMC Cancer ·Tone Hoel Lende,Marie Austdal,(unknown),Ivar Skaland,Einar Gudlaugsson,Jan Terje Kvaløy,Lars A. Akslen,Håvard Søiland,Emiel A. M. Janssen,Jan P. A. Baak	15
7	The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer 2013 ·PLoS ONE ·Marie Klintman,Carina Strand,Cecilia Ahlin,(unknown),Marie-Louise Fjällskog,Dorthe Grabau,Einar Gudlaugsson,Emiel A. M. Janssen,Kristina Lövgren,Ivar Skaland,Pär‐Ola Bendahl,Per Malmström,Jan P. A. Baak,Mårten Fernö	24
8	Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade? 2013 ·PLoS ONE ·Weiwei Feng,Anaís Malpica,Ivar Skaland,Einar Gudlaugsson,Stanley J. Robboy,Ingvild Dalen,Keqin Hua,Xianrong Zhou,Jan P. A. Baak	12
9	The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer 2012 ·Breast Cancer Research and Treatment ·Kristín Jónsdóttir,Hui Zhang,(unknown),Ivar Skaland,(unknown),Benny Björkblom,Eleanor T. Coffey,Einar Gudlaugsson,Rune Smaaland,Emiel A. M. Janssen,Jan P. A. Baak	19
10	Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression 2010 ·Modern Pathology ·Irene Tveiterås Øvestad,Einar Gudlaugsson,Ivar Skaland,Anaís Malpica,Arnold‐Jan Kruse,Emiel A. M. Janssen,Jan P. A. Baak	59
11	Biologic profiling of lymph node negative breast cancers by means of microRNA expression 2010 ·Modern Pathology ·Emiel A. M. Janssen,(unknown),Einar Gudlaugsson,Kristín Jónsdóttir,Ivar Skaland,Håvard Søiland,Jan P. A. Baak	56
12	The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer. 2009 ·SHILAP Revista de lepidopterología ·Ivar Skaland,Emiel A. M. Janssen,Einar Gudlaugsson,(unknown),Jan P. A. Baak	26
13	Digital Image Analysis Improves the Quality of Subjective HER-2 Expression Scoring in Breast Cancer 2008 ·Applied immunohistochemistry & molecular morphology ·Ivar Skaland,Irene Tveiterås Øvestad,Emiel A. M. Janssen,Jan Kłos,Kjell H. Kjellevold,(unknown),Jan P. A. Baak	25
14	Androgen Receptor Determination in Breast Cancer 2008 ·Applied immunohistochemistry & molecular morphology ·Håvard Søiland,Ivar Skaland,Bianca van Diermen,Emiel A. M. Janssen,Hartwig Kørner,Jan Erik Varhaug,Jon Arne Søreide,Jan P. A. Baak	4
15	Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ 2008 ·Human Pathology ·Arnold‐Jan Kruse,Ivar Skaland,(unknown),Emiel A. M. Janssen,Einar Gudlaugsson,Jan P. A. Baak	4
16	Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers 2008 ·Breast Cancer Research and Treatment ·Jan P. A. Baak,Einar Gudlaugsson,Ivar Skaland,(unknown),Jan Kłos,Tone Hoel Lende,Håvard Søiland,Emiel A. M. Janssen,Axel zur Hausen	61
17	Prognostic differences of World Health Organization–assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years 2008 ·Human Pathology ·Ivar Skaland,P. J. van Diest,Emiel A. M. Janssen,Einar Gudlaugsson,Jan P. A. Baak	19
18	Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer 2007 ·Journal of Clinical Pathology ·Ivar Skaland,Irene Tveiterås Øvestad,Emiel A. M. Janssen,Jan Kłos,Kjell H. Kjellevold,(unknown),Jan P. A. Baak	55
19	Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy‐Treated Node‐Negative Breast Cancer patients aged <55 years 2007 ·Analytical Cellular Pathology ·Emiel A. M. Janssen,Håvard Søiland,Ivar Skaland,(unknown),Kjell H. Kjellevold,Arne Nysted,(unknown),Jan P. A. Baak	16
20	Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age 2007 ·Modern Pathology ·Ivar Skaland,Emiel A. M. Janssen,Einar Gudlaugsson,Jan Kłos,Kjell H. Kjellevold,Håvard Søiland,Jan P. A. Baak	91

About Ivar Skaland

Ivar Skaland is a scholar working on Cancer Research, Oncology and Obstetrics and Gynecology, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (22 papers), HER2/EGFR in Cancer Research (13 papers) and Cervical Cancer and HPV Research (13 papers). The work is most often cited by research in Cancer Research (565 citations), Obstetrics and Gynecology (151 citations) and Oncology (467 citations). Ivar Skaland has collaborated with scholars based in Norway, Netherlands and United States. Frequent co-authors include Einar Gudlaugsson, Jan P. A. Baak, Emiel A. M. Janssen, Emiel A. M. Janssen, Håvard Søiland, Jan Kłos, Kjell H. Kjellevold, Anaís Malpica, Irene Tveiterås Øvestad and Bianca van Diermen. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact